Pini Tsukerman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pini Tsukerman. Real-time updates on events, politics, business and more.

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies

November 30, 2022

- Nectin Therapeutics Ltd., (Nectin) a biotechnology company has extended its Series A financing to over $25M for immuno-oncology therapies

United States Pini Tsukerman Moon Fund Cancer Focus Fund Nectin Therapeutics Ltd Nectin Therapeutics Raises

Source: hitconsultant.net

Israeli biotech company begins trial for cancer immuno-oncology solution

November 30, 2022

The company’s product, NTX1088, blocks the harmful overexpression of PVR proteins, which occurs in tumors caused by lung, breast, throat and other cancers.

United States Fabian Tenenbaum Ross Barrett Pini Tsukerman Moon Fund Cancer Focus Fund

Source: jpost.com

Israeli co Nectin Therapeutics raises $25m

November 30, 2022

Jerusalem-based Nectin is developing novel targeted immunotherapies to address resistance to approved immuno-oncology treatments.

United States Fabian Tenenbaum Pini Tsukerman Moon Fund Cancer Focus Fund Nectin Therapeutics

Source: globes.co.il

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Pini Tsukerman News Today

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies

Israeli biotech company begins trial for cancer immuno-oncology solution

Israeli co Nectin Therapeutics raises $25m

Explore More Categories